Serkan Aydemir, MD

About

Infectious Diseases and Clinical Microbiology (ID&CM) Specialist. Fellowship at University College Dublin - HIV Molecular Research Group (2019-2020). Focused primarily on HIV/AIDS, with a strong passion for scientific research and academia. In recent years, I’ve transitioned into the pharmaceutical industry. With a solid background in both infectious diseases and oncology, I am dedicated to driving medical excellence, fostering cross-functional collaboration, and shaping strategies that translate scientific insights into meaningful clinical outcomes for patients.

Experience

• AstraZeneca (İstanbul, Türkiye · Hybrid)
  • Senior Medical Science Manager | Oncology
    Nov 2025 - Present · 8 mos

    Breast Cancer

  • Medical Science Manager | Oncology
    Jan 2024 - Nov 2025 · 1 yr 11 mos

    GU & GYN Cancers

• Johnson & Johnson Innovative Medicine (Full-time · 2 yrs 4 mos)
  • Medical Manager Oncology
    Mar 2023 - Jan 2024 · 11 mos

    All oncology portfolio and pipeline

  • Medical Advisor Oncology
    Oct 2021 - Mar 2023 · 1 yr 6 mos

    Bladder & Prostate Cancer

• University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital (Full-time · 6 yrs 4 mos)
  • Infectious Diseases and Clinical Microbiology (Specialist/ID Physician)
    Jun 2021 - Oct 2021 · 5 mos

  • Infectious Diseases and Clinical Microbiology (Resident)
    Jul 2015 - Jun 2021 · 6 yrs

• Research Fellow at University College Dublin
  Oct 2019 - May 2020 · 8 mos

  Worked in a project as to impact of interferon lambda polymorphisms on treatment outcomes in ART treated people living with HIV under the supervision of Prof. Dr. Paddy Mallon and Willard Tinago. The work was presented at Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, 2020

• Physician at Fatih Devlet Hastanesi
  Sep 2014 - Nov 2014 · 3 mos